Market Analysis - (2019) Volume 4, Issue 4
Assistant Professor, Asian Hospital and Medical Center, Philippines, E-mail: williamshaw025@gmail.com
The global womens health market was estimated at $33.0 billion in 2015, $30.88 billion in 2016, USD 108.0 billion in 2017, USD 39.3 billion in 2018. The womens health market shares postmenopausal osteoporosis, hormonal fertility, endometriosis, birth control, menopause and polycystic ovarian syndrome (PCOS). In 2018, the postmenopausal osteoporosis accounted for the largest portion of the market because of a growing population of elderly women over 40 and the introduction of various drugs to treat menopausal osteoporosis.
Hormone fertility segment predicted strong growth after birth control because of high fertility-related disorders in developed countries. Furthermore, the availability of several hormonal imbalance drugs and market players investment in the segment may improve segment penetration in the coming years. Hormonal imbalances such as thyroid imbalance, prolactin, and estrogen increase in women because life pressure drives market growth.
The size of the global womens market is expected to reach $42.12 billion by 2023 and will increase $ 54.6 billion by 2026, according to a new report by Grand View Research, Inc., which expands at a 4.2% CAGR price during the forecast period. The government and various private organizations are focusing on womens health all over the world, which may drive the market in the coming years. Womens coverage is one of the key factors expected to drive the market in developed countries.
Global Gynaecological Devices Market
The global gynaecological devices market is marked by a high degree of fragmentation due to the presence of numerous large manufacturers, reports Transparency Market Research (TMR) in a new business intelligence study. This leaves ample scope for market consolidation in the near future. Top companies like Cooper Surgical, Boston Scientific Corporation and Olympus Corporation hold distinction on account of their widespread product portfolio and geographical outreach. These companies are struggling to introduce non-invasive devices to serve a larger consumer base which will eventually help expanding their geographical outreach.
The increasing demand for medical help for womencentric health issues is bringing in immense scope for growth in the gynaecological device market. The small regional players play an important role and hold a significantly higher share in the gynaecological device market. The increasing entry barriers and stringent rules and regulations for approval of a product are limiting the entry of new companies. Insufficient funding from venture capitalists is also creating a challenging situation for the entrance of newer companies.
As per projections of a TMR report, the global gynaecological devices market will clock 4.8% CAGR between 2017 and 2023. This will translate opportunities in the market to generate revenue of US$22,589.9 mn by 2023 from US$17,015.9 mn in 2017. In terms of device type, gynaecological surgical devices hold prominence in the market. Rising prevalence of single incision laparoscopic surgeries and advances in conventional endoscopic surgeries account for advances in gynaecological surgical instruments. Geography-wise, North America is a lucrative market for gynaecological devices due to the early adoption of advanced gynaecological devices.
Based on the product type, the global market is segmented into gynaecological imaging devices, surgical devices, and hand instruments. In 2016, surgical devices dominated the market with largest share. High usage of endoscopy devices and female contraceptives is the factor which can be attributable to the largest share.
The need for highly durable and easily autoclavable surgical instruments has been growing increasingly owing to the growing number of surgical procedures globally. Advancement in technology and introduction of highly efficient devices which can provide quick and accurate diagnosis and minimize the operating time are the factors expected to give boost to the market growth in the upcoming years.
The global market for women’s health therapeutics will grow from nearly $33.0 billion in 2015 to nearly $40.6 billion by 2020, with a compound annual growth rate (CAGR) of 4.2% for the period of 2015-2020.
The infertility treatment devices market is expected to reach USD 3,698.92 Million by 2020 from USD 1,822.32 Million in 2015, at a CAGR of 15.21%. Infertility treatment devices are used in assisted reproductive technologies (ART) like in vitro fertilization, intracytoplasmic sperm injection, and surrogacy for the treatment of infertility.
• Engage yourself into the well-organized scientific program and networking environment
• Discuss your ideas and views with pioneers in the fields of gynaecology, obstetrics, midwifery and fertility
• Meet and interact with decision makers from both the private & government hospitals, and clinics from all round the globe
• Review & learn the latest trends and technologies in diagnosis and treatments of diseases related to obstetrics, gynaecology, fertility & management of Women’s Health
• Be a part of the interactive debates, plenary sessions and discussions about the current issues in the area of Women’s health and come to a consensus using evidence-based expert opinion
• Apply the latest developments into your clinical practice
• World-class platform to Exhibit your products and services
• 25+ presentations from Industry and Academia leaders.
• Scientists
• Directors
• Entrepreneurs
• Professors
• Doctors
• Surgeons
• Business delegates
• Community Members
• Students from Academia involved in research of medicine and related fields.
• Dermatologists in training and healthcare professionals
• Drug manufacturing companies and Clinics
• Medical institutions Related Companies/Industries:
• Modern Fertility USA
• Merck & Co. USA
• Ava AG. Switzerland
• Allergan.
• PureWow.
• Hologic, Inc.
• Flo.
• Everly Well.
• Cleveland Clinic
• St Jude Children's Research Hospital
• Johns Hopkins Medicine
• Mayo Clinic Scottsdale AZ
• University of Maryland Medical Center
• M D Anderson Cancer Center
• Massachusetts General Hospital
• Assistance Publique Hôpitaux de Paris
• Memorial Sloan Kettering Cancer Center
• New York Presbyterian / Lower Manhattan Hospital
• Association of Public Health Laboratories
• Society for Public Health Education
• Association of Schools and Programs of Public Health
• Association of Schools and Programs of Public Health
• Centers for Disease Control
• National Cancer Institute
• Accreditation Association for Ambulatory Health Care
• American Association of Colleges of Nursing
• Association for Ambulatory Behavioral Healthcare
• Association of Healthcare Internal Auditors
• Association for Professionals in Infection Control and Epidemiology
• Association for Hospital Medical Education
• College of Healthcare Information Management Executives
• National Association for Home Care and Hospices
• National Association for Healthcare Quality
• The Coalition for Natural Health
• Society for Health Systems.
